AstraZeneca’s Antibody Cocktail Fails to Prevent Covid: Study

AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.

Similar Articles


Most Popular


You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign